Myopia and Presbyopia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Myopia Treatment Devices Market and it is Segmented by Disease Type (Myopia and Presbyopia), Treatment Type (Prescription Lenses, Contact Lenses, Surgery, and Medication), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Myopia and Presbyopia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Myopia and Presbyopia Treatment Market Size

Myopia and Presbyopia Treatment Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 27.47 Billion
Market Size (2030) USD 35.24 Billion
CAGR (2025 - 2030) 5.11 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Myopia and Presbyopia Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Myopia and Presbyopia Treatment Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Myopia and Presbyopia Treatment Market Analysis

The Global Myopia and Presbyopia Treatment Market size is estimated at USD 27.47 billion in 2025, and is expected to reach USD 35.24 billion by 2030, at a CAGR of 5.11% during the forecast period (2025-2030).

The market for myopia and presbyopia is currently growing at a healthy rate, which is majorly associated with the rising number of people with vision impairment and the rapid growth in the geriatric population worldwide.

The COVID-19 pandemic is an unprecedented health concern adversely affecting communities, industries, businesses, and lives worldwide. Great damage has been observed in people's eyesight due to increased screen time. For instance, according to a survey report published in July 2021 by the UK-based Feel Good Contacts, in 2020, due to the lockdown, Indians suffered maximum damage to eyesight due to increased screen time. About 27.5 crore Indians, about 23% of the population, reported their eyesight weakening because of excessive screen time. Moreover, the study Progression of Myopia in School-Aged Children After COVID-19 Home Confinement noted a substantial myopic shift (0.3 diopters) after home confinement amongst children aged 6-8 years.

The prevalence of myopia increased from 1.4 to 3 in 2020 compared to the previous five years globally. The prevalence of vision impairment issues such as myopia is increasing globally at an alarming rate, with significant increases in vision impairment risks from pathologic conditions associated with high myopia, including retinal damage, cataract, and glaucoma. These diseases are causing an elevation in the incidence of visual impairment. The demand for treatment options, like contact, concave, or prescription lenses, has increased tremendously worldwide.

Various countries' governments are focusing on improving patient flow, for which they are also considering increasing the number of eye clinics. The increasing number of eye clinics is augmenting the rise in the procedural volume of eye surgeries, favoring the market studied.

Myopia and Presbyopia Treatment Industry Overview

The global myopia and presbyopia treatment market is highly competitive and consists of several major players. Companies like ALCON Inc., Bausch Health Companies Inc., Johnson & Johnson Vision, Topcon Corporation, Zeimer Ophthalmic Systems AG hold a substantial share in the myopia and presbyopia treatment market.

Myopia and Presbyopia Treatment Market Leaders

  1. Alcon Inc.

  2. Bausch Health Companies Inc.

  3. Johnson & Johnson

  4. Carl Zeiss Meditec AG

  5. Topcon Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Myopia and Presbyopia Treatment Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Myopia and Presbyopia Treatment Market News

  • In October 2021, Allergan, a subsidiary of AbbVie, received approval from the Food and Drug Administration for Vuity (pilocarpine hydrochloric acid ophthalmic solution) 1.25% for the treatment of presbyopia, also known as age-related blurry near vision, in adults.
  • In May 2021, Johnson & Johnson Vision received the US FDA's approval for the ACUVUE Abiliti Overnight Therapeutic Lenses designed to reshape the cornea curve and help treat myopia progression in children.

Myopia and Presbyopia Treatment Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Cases of Vision Impairment
    • 4.2.2 Rising Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Lack of Early Diagnosis
    • 4.3.2 High Cost of Treatment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Disease Type
    • 5.1.1 Myopia
    • 5.1.2 Presbyopia
  • 5.2 By Treatment Type
    • 5.2.1 Prescription Lenses
    • 5.2.2 Contact Lenses
    • 5.2.3 Surgery
    • 5.2.4 Medication
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ALCON Inc.
    • 6.1.2 Bausch Health Companies Inc.
    • 6.1.3 Essilor Luxottica (Essilor Ltd)
    • 6.1.4 Johnson & Johnson Vision
    • 6.1.5 NIDEK CO. LTD
    • 6.1.6 Topcon Corporation
    • 6.1.7 Zeimer Ophthalmic Systems AG
    • 6.1.8 Carl Zeiss Meditec AG
    • 6.1.9 AbbVie
    • 6.1.10 Sydnexis
    • 6.1.11 Regeneron Pharmaceuticals Inc.
    • 6.1.12 Orasis Pharmaceuticals
    • 6.1.13 The Cooper Companies Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Myopia and Presbyopia Treatment Industry Segmentation

As per the scope of the report, myopia is the condition in which incoming light does not directly focus on the retina but in front of it. Presbyopia becomes more frequent. Presbyopia is the condition in which incoming light focuses behind the retina, leading to difficulty focusing on close-up objects. The Myopia and Presbyopia Treatment Market is Segmented by Disease Type (Myopia and Presbyopia), Treatment Type (Prescription Lenses, Contact Lenses, Surgery, and Medication), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Disease Type Myopia
Presbyopia
By Treatment Type Prescription Lenses
Contact Lenses
Surgery
Medication
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Myopia and Presbyopia Treatment Market Research FAQs

How big is the Global Myopia and Presbyopia Treatment Market?

The Global Myopia and Presbyopia Treatment Market size is expected to reach USD 27.47 billion in 2025 and grow at a CAGR of 5.11% to reach USD 35.24 billion by 2030.

What is the current Global Myopia and Presbyopia Treatment Market size?

In 2025, the Global Myopia and Presbyopia Treatment Market size is expected to reach USD 27.47 billion.

Who are the key players in Global Myopia and Presbyopia Treatment Market?

Alcon Inc., Bausch Health Companies Inc., Johnson & Johnson, Carl Zeiss Meditec AG and Topcon Corporation are the major companies operating in the Global Myopia and Presbyopia Treatment Market.

Which is the fastest growing region in Global Myopia and Presbyopia Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Myopia and Presbyopia Treatment Market?

In 2025, the North America accounts for the largest market share in Global Myopia and Presbyopia Treatment Market.

What years does this Global Myopia and Presbyopia Treatment Market cover, and what was the market size in 2024?

In 2024, the Global Myopia and Presbyopia Treatment Market size was estimated at USD 26.07 billion. The report covers the Global Myopia and Presbyopia Treatment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Myopia and Presbyopia Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Myopia and Presbyopia Treatment Industry Report

Statistics for the 2025 Global Myopia and Presbyopia Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Myopia and Presbyopia Treatment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Myopia and Presbyopia Treatment Market Report Snapshots